{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:21:16Z","timestamp":1795022476617,"version":"4.10.1"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"1.3.5 project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University","award":["2021HXFH001"],"award-info":[{"award-number":["2021HXFH001"]}]},{"name":"1.3.5 project for Artificial Intelligence West China Hospital, Sichuan University","award":["ZYAI24030"],"award-info":[{"award-number":["ZYAI24030"]}]},{"name":"China Telecom Sichuan Company Biliary Tract Tumor Big Data Platform and Application Phase I R&D Project","award":["312230752"],"award-info":[{"award-number":["312230752"]}],"id":[{"id":"https:\/\/ror.org\/05p67dv18","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China for Young Scientists Fund","award":["82203782"],"award-info":[{"award-number":["82203782"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Sichuan Science and Technology Program","award":["2024YFFK0384"],"award-info":[{"award-number":["2024YFFK0384"]}]},{"name":"Sichuan Science and Technology Program","award":["2024YFFK0385"],"award-info":[{"award-number":["2024YFFK0385"]}]},{"name":"Science and Technology project of the Health planning committee of Sichuan","award":["24QNMP031"],"award-info":[{"award-number":["24QNMP031"]}]},{"name":"Sichuan University-Sui Ning School-local Cooperation project","award":["2022CDSN-18"],"award-info":[{"award-number":["2022CDSN-18"]}],"id":[{"id":"https:\/\/ror.org\/011ashp19","id-type":"ROR","asserted-by":"crossref"}]},{"name":"(Qilu) Clinical Research of Sichuan Anticancer Association","award":["XH2023-032"],"award-info":[{"award-number":["XH2023-032"]}]},{"name":"(Qilu) Clinical Research of Sichuan Anticancer Association","award":["XH2023-502"],"award-info":[{"award-number":["XH2023-502"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,24]]},"abstract":"<jats:p>\n                    The causal links between serum amino acids (AAs) and hepatobiliary neoplasms remain unclear. This study aimed to systematically investigate these associations using Mendelian randomization (MR). Summary-level data on 20 serum AAs were obtained from publicly available genome-wide association studies. Genome-wide association studies data on hepatobiliary neoplasms \u2013 including primary liver cancer (PLC), hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), gallbladder and extrahepatic bile duct carcinoma, secondary liver cancer, benign liver tumors, and benign tumors of the extrahepatic bile ducts \u2013 were derived from FinnGen and 2 UK Biobank-based studies. A meta-analysis was conducted to calculate pooled effect sizes. Inverse variance weighting was the primary method, supplemented by MR-Egger, weighted median, MR.RAPS, maximum likelihood, and MR-PRESSO methods for sensitive analyses. Higher serum methionine was associated with lower risks of PLC (OR\u2005=\u20050.84, 95% CI: 0.72\u20130.97,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.021) and HCC (OR\u2005=\u20050.87, 95% CI: 0.80\u20130.94,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), but not ICC. Alanine increased PLC risk (OR\u2005=\u20051.19, 95% CI: 1.00\u20131.42,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.047), with no significant effect on HCC or ICC. No AAs were linked to gallbladder and extrahepatic bile duct carcinoma or secondary liver cancer. For benign tumors, aspartate (OR\u2005=\u20051.13, 95% CI: 1.01\u20131.26,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.037), cysteine (OR\u2005=\u20050.72, 95% CI: 0.57\u20130.92,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.008), and lysine (OR\u2005=\u20051.49, 95% CI: 1.15\u20131.93,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.003) were significantly associated with benign liver tumors or benign tumors of the extrahepatic bile ducts. This study offers robust evidence of causal associations between specific serum AAs and hepatobiliary neoplasms, emphasizing their potential as biomarkers and modifiable targets for early intervention.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000045491","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T19:01:41Z","timestamp":1761332501000},"page":"e45491","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Unveiling causal links between serum amino acid levels and risk of hepatobiliary neoplasms by Mendelian randomization study"],"prefix":"10.1097","volume":"104","author":[{"given":"Aoqiang","family":"Zhai","sequence":"first","affiliation":[{"name":"Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China"},{"name":"Research Center for Biliary Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ren","sequence":"additional","affiliation":[{"name":"Division of Vascular Surgery, Department of General Surgery, West China Hospital, Sichuan University\/West China School of Nursing, Sichuan University, Chengdu, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Zhong","sequence":"additional","affiliation":[{"name":"Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China"},{"name":"Research Center for Biliary Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Zou","sequence":"additional","affiliation":[{"name":"Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China"},{"name":"Research Center for Biliary Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China"},{"name":"Research Center for Biliary Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwen","family":"Jin","sequence":"additional","affiliation":[{"name":"Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China"},{"name":"Research Center for Biliary Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijie","family":"Hu","sequence":"additional","affiliation":[{"name":"Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China"},{"name":"Research Center for Biliary Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyu","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China"},{"name":"Research Center for Biliary Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261118","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R2-20261118","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma.","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"key":"R3-20261118","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2017.05.014","article-title":"Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.","volume":"67","author":"Calderaro","year":"2017","journal-title":"J Hepatol"},{"key":"R4-20261118","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jhep.2019.06.001","article-title":"Molecular and histological correlations in liver cancer.","volume":"71","author":"Calderaro","year":"2019","journal-title":"J Hepatol"},{"key":"R5-20261118","doi-asserted-by":"crossref","first-page":"djx030","DOI":"10.1093\/jnci\/djx030","article-title":"Annual Report to the Nation on the Status of Cancer, 1975-2014, featuring survival.","volume":"109","author":"Jemal","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"R6-20261118","doi-asserted-by":"crossref","first-page":"101164","DOI":"10.1016\/j.jhepr.2024.101164","article-title":"Tumor organoids for primary liver cancers: a systematic review of current applications in diagnostics, disease modeling, and drug screening.","volume":"6","author":"Qureshi","year":"2024","journal-title":"JHEP Rep"},{"key":"R7-20261118","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management.","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R8-20261118","first-page":"7","article-title":"Cancer statistics, 2022.","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"R9-20261118","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","article-title":"Gallbladder cancer.","volume":"8","author":"Roa","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"R10-20261118","first-page":"99","article-title":"Gallbladder cancer: epidemiology and outcome.","volume":"6","author":"Hundal","year":"2014","journal-title":"Clin Epidemiol"},{"key":"R11-20261118","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/13651820802029435","article-title":"Development of a swine model of secondary liver tumor from a genetically induced swine fibroblast cell line.","volume":"10","author":"Abbas","year":"2008","journal-title":"HPB (Oxford)"},{"key":"R12-20261118","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000509145","article-title":"Benign liver tumors.","volume":"36","author":"Oldhafer","year":"2020","journal-title":"Visc Med"},{"key":"R13-20261118","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular carcinoma.","volume":"365","author":"El-Serag","year":"2011","journal-title":"N Engl J Med"},{"key":"R14-20261118","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma.","volume":"379","author":"Forner","year":"2012","journal-title":"Lancet"},{"key":"R15-20261118","first-page":"198","article-title":"Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians.","volume":"73","author":"Moris","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"R16-20261118","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12876-016-0527-z","article-title":"Increasing mortality in the United States from cholangiocarcinoma: an analysis of the National Center for Health Statistics Database.","volume":"16","author":"Yao","year":"2016","journal-title":"BMC Gastroenterol"},{"key":"R17-20261118","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1016\/j.cell.2023.09.011","article-title":"Arginine reprograms metabolism in liver cancer via RBM39.","volume":"186","author":"Mossmann","year":"2023","journal-title":"Cell"},{"key":"R18-20261118","doi-asserted-by":"crossref","first-page":"111691","DOI":"10.1016\/j.celrep.2022.111691","article-title":"Branched-chain amino acid catabolism breaks glutamine addiction to sustain hepatocellular carcinoma progression.","volume":"41","author":"Yang","year":"2022","journal-title":"Cell Rep"},{"key":"R19-20261118","doi-asserted-by":"crossref","first-page":"1242059","DOI":"10.3389\/fmolb.2023.1242059","article-title":"Glutamine metabolic reprogramming in hepatocellular carcinoma.","volume":"10","author":"Ye","year":"2023","journal-title":"Front Mol Biosci"},{"key":"R20-20261118","doi-asserted-by":"crossref","first-page":"15795","DOI":"10.1021\/acsomega.2c00885","article-title":"Serum amino acid profiles predict the development of hepatocellular carcinoma in patients with chronic HBV infection.","volume":"7","author":"Wu","year":"2022","journal-title":"ACS Omega"},{"key":"R21-20261118","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3390\/metabo2040701","article-title":"Differentiating hepatocellular carcinoma from hepatitis C using metabolite profiling.","volume":"2","author":"Wei","year":"2012","journal-title":"Metabolites"},{"key":"R22-20261118","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3390\/jpm14030262","article-title":"Identifying proteins and amino acids associated with liver cancer risk: a study utilizing Mendelian randomization and bulk RNA sequencing analysis.","volume":"14","author":"Ma","year":"2024","journal-title":"J Pers Med"},{"key":"R23-20261118","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.clnu.2023.10.019","article-title":"Association of plasma branched-chain amino acid with multiple cancers: a Mendelian randomization analysis.","volume":"42","author":"Xu","year":"2023","journal-title":"Clin Nutr"},{"key":"R24-20261118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u201cMendelian randomization\u201d: can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Smith","year":"2003","journal-title":"Int J Epidemiol"},{"key":"R25-20261118","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41588-022-01270-1","article-title":"Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases.","volume":"55","author":"Chen","year":"2023","journal-title":"Nat Genet"},{"key":"R26-20261118","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"R27-20261118","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41588-018-0184-y","article-title":"Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies.","volume":"50","author":"Zhou","year":"2018","journal-title":"Nat Genet"},{"key":"R28-20261118","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1038\/s41588-021-00954-4","article-title":"A generalized linear mixed model association tool for biobank-scale data.","volume":"53","author":"Jiang","year":"2021","journal-title":"Nat Genet"},{"key":"R29-20261118","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jare.2023.05.008","article-title":"Insights into modifiable risk factors of erectile dysfunction, a wide-angled Mendelian randomization study.","volume":"58","author":"Xiong","year":"2024","journal-title":"J Adv Res"},{"key":"R30-20261118","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R31-20261118","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R32-20261118","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R33-20261118","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0955-2863(90)90070-2","article-title":"Methionine metabolism in mammals.","volume":"1","author":"Finkelstein","year":"1990","journal-title":"J Nutr Biochem"},{"key":"R34-20261118","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jhep.2013.04.031","article-title":"Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.","volume":"59","author":"Frau","year":"2013","journal-title":"J Hepatol"},{"key":"R35-20261118","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1152\/physrev.00047.2011","article-title":"S-adenosylmethionine in liver health, injury, and cancer.","volume":"92","author":"Lu","year":"2012","journal-title":"Physiol Rev"},{"key":"R36-20261118","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1096\/fj.00-0121com","article-title":"S-adenosylmethionine regulates MAT1A and MAT2A gene expression in cultured rat hepatocytes: a new role for S-adenosylmethionine in the maintenance of the differentiated status of the liver.","volume":"14","author":"Garc\u00eda-Trevijano","year":"2000","journal-title":"FASEB J"},{"key":"R37-20261118","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.1073\/pnas.0509531103","article-title":"S-adenosylmethionine stabilizes cystathionine beta-synthase and modulates redox capacity.","volume":"103","author":"Prudova","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R38-20261118","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/hep.22231","article-title":"S-adenosylmethionine inhibits lipopolysaccharide-induced gene expression via modulation of histone methylation.","volume":"47","author":"Ara","year":"2008","journal-title":"Hepatology"},{"key":"R39-20261118","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/bj3420021","article-title":"S-adenosylmethionine attenuates the lipopolysaccharide-induced expression of the gene for tumour necrosis factor alpha.","volume":"342 (Pt 1)","author":"Watson","year":"1999","journal-title":"Biochem J"},{"key":"R40-20261118","first-page":"4979","article-title":"Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: a long-term study.","volume":"52","author":"Pascale","year":"1992","journal-title":"Cancer Res"},{"key":"R41-20261118","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jhep.2012.04.041","article-title":"S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility.","volume":"57","author":"Anstee","year":"2012","journal-title":"J Hepatol"},{"key":"R42-20261118","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/hep.32232","article-title":"IL-6-induced cGGNBP2 encodes a protein to promote cell growth and metastasis in intrahepatic cholangiocarcinoma.","volume":"75","author":"Li","year":"2022","journal-title":"Hepatology"},{"key":"R43-20261118","first-page":"31","article-title":"Cancer metabolism: a novel perspective on precision diagnosis and treatment for liver cancer.","volume":"58","author":"Ning","year":"2020","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"R44-20261118","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1476-4598-10-70","article-title":"The metabolic advantage of tumor cells.","volume":"10","author":"Isra\u00ebl","year":"2011","journal-title":"Mol Cancer"},{"key":"R45-20261118","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s40471-017-0128-6","article-title":"Recent developments in Mendelian randomization studies.","volume":"4","author":"Zheng","year":"2017","journal-title":"Curr Epidemiol Rep"},{"key":"R46-20261118","first-page":"1","article-title":"Arginine metabolism: nitric oxide and beyond.","volume":"336 (Pt 1)","author":"Wu","year":"1998","journal-title":"Biochem J"},{"key":"R47-20261118","doi-asserted-by":"crossref","first-page":"103940","DOI":"10.1016\/j.drudis.2024.103940","article-title":"Treating liver cancer through arginine depletion.","volume":"29","author":"Prasad","year":"2024","journal-title":"Drug Discov Today"},{"key":"R48-20261118","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.3390\/nu13124503","article-title":"Arginine and arginases modulate metabolism, tumor microenvironment and prostate cancer progression.","volume":"13","author":"Matos","year":"2021","journal-title":"Nutrients"},{"key":"R49-20261118","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.metabol.2019.06.011","article-title":"Amino acid signature predictive of incident prediabetes: a case-control study nested within the longitudinal pathobiology of prediabetes in a biracial cohort.","volume":"98","author":"Owei","year":"2019","journal-title":"Metabolism"},{"key":"R50-20261118","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12864-022-08442-7","article-title":"Effects of glutamate and aspartate on prostate cancer and breast cancer: a Mendelian randomization study.","volume":"23","author":"Lin","year":"2022","journal-title":"BMC Genomics"},{"key":"R51-20261118","doi-asserted-by":"crossref","first-page":"1270336","DOI":"10.3389\/fendo.2023.1270336","article-title":"Exploring blood metabolites and thyroid disorders: a bidirectional Mendelian randomization study.","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R52-20261118","doi-asserted-by":"crossref","first-page":"9581","DOI":"10.3390\/ijms23179581","article-title":"Cysteine regulates oxidative stress and glutathione-related antioxidative capacity before and after colorectal tumor resection.","volume":"23","author":"Chiang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R53-20261118","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijbiomac.2019.12.025","article-title":"Construction and characterization of protein-based cysteine nanosensor for the real time measurement of cysteine level in living cells.","volume":"143","author":"Singh","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"R54-20261118","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1158\/1541-7786.MCR-20-0024","article-title":"Dual regulation of histone methylation by mTOR complexes controls glioblastoma tumor cell growth via EZH2 and SAM.","volume":"18","author":"Harachi","year":"2020","journal-title":"Mol Cancer Res"},{"key":"R55-20261118","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/liv.14692","article-title":"The biological process of lysine-tRNA charging is therapeutically targetable in liver cancer.","volume":"41","author":"Zhang","year":"2021","journal-title":"Liver Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045491","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:01:41Z","timestamp":1795021301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":55,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045491","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"2025-05-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}